Screener
Jade Biosciences JBIO Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
FAQ
- What is Jade Biosciences's shares (diluted)?
- Jade Biosciences (JBIO) reported shares (diluted) of 57.8M in Q1 2026.
- How has Jade Biosciences's shares (diluted) changed year-over-year?
- Jade Biosciences's shares (diluted) increased by 1731.0% year-over-year, from 3.2M to 57.8M.
- What is the long-term trend for Jade Biosciences's shares (diluted)?
- Over 3 years (2022 to 2025), Jade Biosciences's shares (diluted) has grown at a 1.6% compound annual growth rate (CAGR), from 97.7M to 102.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Jade Biosciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude